The effect of recombinant human erythropoietin on postoperative anemia in orthognathic patients Chinese

Department of Anesthesiology, Ninth People's Hospital, Shanghai Second Medical University. Shanghai 200011, China.

Shanghai Kou Qiang Yi Xue [Shanghai Journal of Stomatology]. 2004;13((4):):249-51.
PURPOSE To observe the effect of rhEPO on postoperative anemia in orthognathic patients. METHODS 31 patients had 500-1200 ml blood loss during orthognathic operation, who were divided into two groups randomly, the experiment group and the control group. The patients in the experiment group received rhEPO 6000IU subcutaneously for 3 times in a week and Ferrost sulfatis Et vitamini-medtech 1 tablet per day via oral administration for 12 days after operation, while the patients in the control group only received the same dose of Ferrost sulfatis Et vitamini-medtech. The loss of blood of the patients during operation were estimated and recorded. Their Hb and Hct were mensured before operation, and in the first, third, seventh-twelfth day after operation. RESULTS In the twelfth day after operation, the Hb and Hct of the patients in the experiment group had a significantly higher increase than that in the control group (P<0. 05). CONCLUSIONS rhEPO combined Ferrost sulfatis Et vitamini-medtech are suitable to apply in orthognathic patients with anemia after operation, which may effectively accelerate the recovery of their anemia, and avoid transfusion of blood.
Study details
Language : Chinese
Credits : Bibliographic data from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine